Prognostic Value of Performance Status, Albumin, and CRP in Last-Line Chemotherapy for Pancreatic vs. Other Gastrointestinal Cancers—Simple Tools Matter

Prognostic Value of Performance Status, Albumin, and CRP in Last-Line Chemotherapy for Pancreatic vs. Other Gastrointestinal Cancers—Simple Tools Matter

Patients with advanced gastrointestinal cancers often receive chemotherapy near the end of life (EoL), raising concerns about overtreatment. The PALLiON trial, a cluster-randomized trial, assessed the impact of a complex intervention on frequency of EoL treatment; the intervention involved palliativ...

Full description

Saved in:
Bibliographic Details
Main Authors: Arne Westgaard, Aleksandra Pirnat, Marianne Jensen Hjermstad, Nina Aass, Stein Kaasa, Olav Faisal Dajani
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Current Oncology
Subjects:
pancreatic adenocarcinoma
gastrointestinal cancer
end-of-life chemotherapy
palliative care
Online Access:https://www.mdpi.com/1718-7729/31/9/404
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1718-7729/31/9/404

Similar Items